These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37768595)

  • 21. Generative Deep Learning for Targeted Compound Design.
    Sousa T; Correia J; Pereira V; Rocha M
    J Chem Inf Model; 2021 Nov; 61(11):5343-5361. PubMed ID: 34699719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OptiMol: Optimization of Binding Affinities in Chemical Space for Drug Discovery.
    Boitreaud J; Mallet V; Oliver C; Waldispühl J
    J Chem Inf Model; 2020 Dec; 60(12):5658-5666. PubMed ID: 32986426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving drug discovery with a hybrid deep generative model using reinforcement learning trained on a Bayesian docking approximation.
    Xiong Y; Wang Y; Wang Y; Li C; Yusong P; Wu J; Wang Y; Gu L; Butch CJ
    J Comput Aided Mol Des; 2023 Nov; 37(11):507-517. PubMed ID: 37550462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FAME: Fragment-based Conditional Molecular Generation for Phenotypic Drug Discovery.
    Pham TH; Xie L; Zhang P
    Proc SIAM Int Conf Data Min; 2022; 2022():720-728. PubMed ID: 35509686
    [No Abstract]   [Full Text] [Related]  

  • 25. Semisupervised Generative Autoencoder for Single-Cell Data.
    Trong TN; Mehtonen J; González G; Kramer R; Hautamäki V; Heinäniemi M
    J Comput Biol; 2020 Aug; 27(8):1190-1203. PubMed ID: 31794242
    [No Abstract]   [Full Text] [Related]  

  • 26. De novo generation of dual-target ligands using adversarial training and reinforcement learning.
    Lu F; Li M; Min X; Li C; Zeng X
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of Generative Autoencoder in De Novo Molecular Design.
    Blaschke T; Olivecrona M; Engkvist O; Bajorath J; Chen H
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29235269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-Based Drug Design with a Deep Hierarchical Generative Model.
    Weller JA; Rohs R
    J Chem Inf Model; 2024 Aug; 64(16):6450-6463. PubMed ID: 39058534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MGCVAE: Multi-Objective Inverse Design via Molecular Graph Conditional Variational Autoencoder.
    Lee M; Min K
    J Chem Inf Model; 2022 Jun; 62(12):2943-2950. PubMed ID: 35666276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular substructure tree generative model for de novo drug design.
    Wang S; Song T; Zhang S; Jiang M; Wei Z; Li Z
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35039853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances and Challenges in De Novo Drug Design Using Three-Dimensional Deep Generative Models.
    Xie W; Wang F; Li Y; Lai L; Pei J
    J Chem Inf Model; 2022 May; 62(10):2269-2279. PubMed ID: 35544331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TransGEM: a molecule generation model based on Transformer with gene expression data.
    Liu Y; Yu H; Duan X; Zhang X; Cheng T; Jiang F; Tang H; Ruan Y; Zhang M; Zhang H; Zhang Q
    Bioinformatics; 2024 May; 40(5):. PubMed ID: 38632084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-based
    Li Y; Pei J; Lai L
    Chem Sci; 2021 Oct; 12(41):13664-13675. PubMed ID: 34760151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive assessment of deep generative architectures for de novo drug design.
    Wang M; Sun H; Wang J; Pang J; Chai X; Xu L; Li H; Cao D; Hou T
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34929743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring Low-Toxicity Chemical Space with Deep Learning for Molecular Generation.
    Yang Y; Wu Z; Yao X; Kang Y; Hou T; Hsieh CY; Liu H
    J Chem Inf Model; 2022 Jul; 62(13):3191-3199. PubMed ID: 35713712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deep Generative Models for Molecular Science.
    Jørgensen PB; Schmidt MN; Winther O
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29405647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular generative model based on conditional variational autoencoder for de novo molecular design.
    Lim J; Ryu S; Kim JW; Kim WY
    J Cheminform; 2018 Jul; 10(1):31. PubMed ID: 29995272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accelerating the discovery of anticancer peptides targeting lung and breast cancers with the Wasserstein autoencoder model and PSO algorithm.
    Yang L; Yang G; Bing Z; Tian Y; Huang L; Niu Y; Yang L
    Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35945135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptionally Conditional Recurrent Neural Network for De Novo Drug Design.
    Matsukiyo Y; Tengeiji A; Li C; Yamanishi Y
    J Chem Inf Model; 2024 Aug; 64(15):5844-5852. PubMed ID: 39049516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LOGICS: Learning optimal generative distribution for designing de novo chemical structures.
    Bae B; Bae H; Nam H
    J Cheminform; 2023 Sep; 15(1):77. PubMed ID: 37674239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.